The Latest
-
Heron Therapeutics: HTX-011 Will Eventually Be Approved, Says Analyst
-
If you don’t get more stimulus checks this summer from Uncle Sam, here’s how the stock market may react
-
Market outlook as Pfizer sparks coronavirus vaccine optimism
-
COVID SCIENCE-Blood cell damage may explain low oxygen levels; two vaccines show promise in early testing